Matches in Nanopublications for { ?s ?p "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP553650.RAfZbNSs_h8qSj09PEg0tkXb9LHF5KBCBqVVncvoGbJhs130_assertion description "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553650.RAfZbNSs_h8qSj09PEg0tkXb9LHF5KBCBqVVncvoGbJhs130_provenance.
- NP278512.RA8XcwOCLWk0FrjhWxSvwNmLaAfepD5Wgn-O9wpJJ6NXo130_assertion description "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278512.RA8XcwOCLWk0FrjhWxSvwNmLaAfepD5Wgn-O9wpJJ6NXo130_provenance.
- NP411019.RAeeWWLDumQtGOiQa39UbVjHRavfJtosneo4oyTy098R8130_assertion description "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411019.RAeeWWLDumQtGOiQa39UbVjHRavfJtosneo4oyTy098R8130_provenance.
- NP191855.RAyOSqWbtiRI-wg3oLWuQ6eVAMFZ2Qou5BZJAMPwe8Kfc130_assertion description "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP191855.RAyOSqWbtiRI-wg3oLWuQ6eVAMFZ2Qou5BZJAMPwe8Kfc130_provenance.
- NP876805.RAcQn546g9kSMPi1u-1NQxucXJgP_sEjFYqWs01DIx5PI130_assertion description "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876805.RAcQn546g9kSMPi1u-1NQxucXJgP_sEjFYqWs01DIx5PI130_provenance.
- NP562915.RASRRcDPDK-S_kj8TsZi8QW2eEtKkg4p48VqQW4NvgNQs130_assertion description "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562915.RASRRcDPDK-S_kj8TsZi8QW2eEtKkg4p48VqQW4NvgNQs130_provenance.
- NP562912.RAusX4NR8yWLz4DjpDxlvHNLRhhFJ1ZNykRSJ_GUFIY3c130_assertion description "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562912.RAusX4NR8yWLz4DjpDxlvHNLRhhFJ1ZNykRSJ_GUFIY3c130_provenance.
- NP876785.RA3QdOvTgcA8QMhLfY24w6dZPkRpWIi_reu1MqQDKS4Es130_assertion description "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876785.RA3QdOvTgcA8QMhLfY24w6dZPkRpWIi_reu1MqQDKS4Es130_provenance.
- NP562908.RA4I-VkDgd35zb73riAOYdJt3Nnh37bF3rEV7SUWFb0CU130_assertion description "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562908.RA4I-VkDgd35zb73riAOYdJt3Nnh37bF3rEV7SUWFb0CU130_provenance.
- NP562909.RA8dhd0y_8aHnYU2DCMP-2o7OKfMIcJ_Xiq5cjPe56JOk130_assertion description "[The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562909.RA8dhd0y_8aHnYU2DCMP-2o7OKfMIcJ_Xiq5cjPe56JOk130_provenance.